VAM
BIO icon

Veritas Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Veritas Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-543,335
Closed -$165M – 22
2025
Q4 		$165M Sell
543,335
-300,704
-36% -$93.8M 1.68% 18
2025
Q3 		$237M Sell
844,039
-19,102
-2% -$5.2M 2.53% 15
2025
Q2 		$208M Sell
863,141
-49,981
-5% -$11.8M 2.08% 15
2025
Q1 		$222M Sell
913,122
-63,705
-7% -$19.2M 2.25% 16
2024
Q4 		$321M Sell
976,827
-109,652
-10% -$37.2M 2.99% 16
2024
Q3 		$364M Sell
1,086,479
-42,332
-4% -$13.4M 2.69% 17
2024
Q2 		$308M Sell
1,128,811
-18,286
-2% -$5.32M 2.33% 18
2024
Q1 		$397M Buy
1,147,097
+64,202
+6% +$21.1M 2.88% 15
2023
Q4 		$350M Sell
1,082,895
-30,648
-3% -$9.61M 2.52% 16
2023
Q3 		$399M Sell
1,113,543
-23,906
-2% -$9.22M 3% 15
2023
Q2 		$431M Sell
1,137,449
-13,489
-1% -$5.49M 3% 15
2023
Q1 		$551M Sell
1,150,938
-1,349
-0.1% -$631K 4.07% 12
2022
Q4 		$485M Buy
1,152,287
+155,666
+16% +$62.8M 3.97% 14
2022
Q3 		$416M Buy
996,621
+229,859
+30% +$115M 3.44% 16
2022
Q2 		$380M Buy
+766,762
New +$399M 2.83% 16

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Veritas Asset Management's BIO Position: Q1 2026 in Review

Veritas Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 543,335 shares — an estimated $165M sold.

Veritas Asset Management first reported a position in BIO in Q2 2022 and held it in 15 quarters. The position peaked at $551M in Q1 2023. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Veritas Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Veritas Asset Management sold 543,335 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $165M.
  • Veritas Asset Management first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 15 quarters.
  • Veritas Asset Management's Bio-Rad Laboratories Class A position peaked at $551M in Q1 2023.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Veritas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.